1 challenge in vaccine improvement is economic: A lot of the disorders most demanding a vaccine, which include HIV, malaria and tuberculosis, exist principally in very poor nations. Pharmaceutical firms and biotechnology providers have very little incentive to produce vaccines for these ailments